These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 17427356)

  • 1. Against anti-health epidemiology: corporate obstruction of public health via manipulation of epidemiology.
    Egilman D; Howe S
    Int J Occup Environ Health; 2007; 13(1):118-24. PubMed ID: 17427356
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Corporate corruption of science--the case of chromium(VI).
    Egilman D; Scout
    Int J Occup Environ Health; 2006; 12(2):169-76. PubMed ID: 16722197
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Industry influence on occupational and environmental public health.
    Huff J
    Int J Occup Environ Health; 2007; 13(1):107-17. PubMed ID: 17427355
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Maximizing profit and endangering health: corporate strategies to avoid litigation and regulation.
    Bohme SR; Zorabedian J; Egilman DS
    Int J Occup Environ Health; 2005; 11(4):338-48. PubMed ID: 16350467
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lead IARC towards compliance with WHO/IARC Declaration of Interests (DOI) policy.
    Sass J
    Int J Occup Environ Health; 2002; 8(3):277-8. PubMed ID: 12358083
    [No Abstract]   [Full Text] [Related]  

  • 6. Ethical oxymora for risk assessment practitioners.
    Greenberg MR; Spiro H; McIntyre R
    Account Res; 1991; 1(4):245-57. PubMed ID: 11651458
    [No Abstract]   [Full Text] [Related]  

  • 7. Corporate corruption of medical literature: asbestos studies concealed by W.R. Grace & Co.
    Egilman D; Wallace W; Hom C
    Account Res; 1998 Jan; 6(1-2):127-47. PubMed ID: 11660587
    [No Abstract]   [Full Text] [Related]  

  • 8. Changing conclusions on secondhand smoke in a sudden infant death syndrome review funded by the tobacco industry.
    Tong EK; England L; Glantz SA
    Pediatrics; 2005 Mar; 115(3):e356-66. PubMed ID: 15741361
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Corporate influences on epidemiology.
    Pearce N
    Int J Epidemiol; 2008 Feb; 37(1):46-53. PubMed ID: 18245050
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Re: Implementation of WHO Guidelines on Disclosure of Interest by members of WHO Expert Panels.
    Axelson O; Castleman B; Epstein S; Franco G; Giannasi F; Grandjean P; Greenberg M; Hooper K; Huff J; Jacobson M; Joshi TK; Kulkarni GK; LaDou J; Mazaheri M; Mekonnen Y; Melnick R; Mirabelli D; Ofrin R; Partanen T; Pott F; Sass J; Soskolne CL; Suplido ML; Terracini B; Tomatis L; Ungvary G; Watterson A; Wesseling C; Yassi A
    Int J Occup Environ Health; 2002; 8(3):271-3. PubMed ID: 12358082
    [No Abstract]   [Full Text] [Related]  

  • 11. Controversies at international organizations over asbestos industry influence.
    Castleman BI
    Int J Health Serv; 2001; 31(1):193-202. PubMed ID: 11271644
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ethics, morality, and conflicting interests: how questionable professional integrity in some scientists supports global corporate influence in public health.
    Baur X; Budnik LT; Ruff K; Egilman DS; Lemen RA; Soskolne CL
    Int J Occup Environ Health; 2015; 21(2):172-5. PubMed ID: 25730664
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Chemical exposures of women workers in the plastics industry with particular reference to breast cancer and reproductive hazards.
    DeMatteo R; Keith MM; Brophy JT; Wordsworth A; Watterson AE; Beck M; Ford AR; Gilbertson M; Pharityal J; Rootham M; Scott DN
    New Solut; 2012; 22(4):427-48. PubMed ID: 23207955
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Science with health consequences.
    Cranor CF
    Int J Occup Environ Health; 2006; 12(2):177-9. PubMed ID: 16722198
    [No Abstract]   [Full Text] [Related]  

  • 15. The safety of many significant chemicals to which humans may be exposed.
    Jacobson MF; Clapp R; Legator M; Lijinsky W; Reuber MD
    Int J Occup Environ Health; 2002; 8(3):279-80. PubMed ID: 12358084
    [No Abstract]   [Full Text] [Related]  

  • 16. Dow chemical scientists respond to allegations of suppression of research results.
    Burns CJ; Kociba R
    J Occup Environ Med; 2003 Sep; 45(9):914-5. PubMed ID: 14506335
    [No Abstract]   [Full Text] [Related]  

  • 17. IARC monographs, industry influence, and upgrading, downgrading, and under-grading chemicals: a personal point of view. International Agency for Research on Cancer.
    Huff J
    Int J Occup Environ Health; 2002; 8(3):249-70. PubMed ID: 12358081
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Commentary: the role of toxicology in prevention and precaution.
    Silbergeld EK
    Int J Occup Med Environ Health; 2004; 17(1):91-102. PubMed ID: 15212211
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Commentary: Lack of scientific influences on epidemiology.
    Phillips CV
    Int J Epidemiol; 2008 Feb; 37(1):59-64; discussion 65-8. PubMed ID: 18245053
    [No Abstract]   [Full Text] [Related]  

  • 20. The Production of Corporate Research to Manufacture Doubt About the Health Hazards of Products: An Overview of the Exponent Bakelite® Simulation Study.
    Egilman D
    New Solut; 2018 Aug; 28(2):179-201. PubMed ID: 29712511
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.